TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive Cancer Deaths Level Off For First Time, Klausner Tells House Appropriators. February 18, 2000
TCL Archive In Brief: Wyeth-Ayerst To donate hormone Replacement Therapy To NIH For Women’s Health Initiative April 23, 1993
